IOVANCE BIOTHERAPEUTICS INC IOV (0JDK.L) Financials
0JDK.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 852.3 million | 178.3 million |
2023-06-30 | 757.3 million | 178.7 million |
2023-03-31 | 824.8 million | 157.9 million |
2022-12-31 | 664.0 million | 164.3 million |
0JDK.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -87.7 million | 15.8 million |
2023-06-30 | -103.5 million | 16.7 million |
2023-03-31 | -105.5 million | 15.7 million |
2022-12-31 | -80.7 million | 19.5 million |
0JDK.L Net Income
No data available :(
0JDK.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 361.4 million | - | - |
2023-06-30 | 250.9 million | - | - |
2023-03-31 | 626.3 million | - | - |
2022-12-31 | 471.8 million | - | - |
0JDK.L Shares Outstanding
0JDK.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 3.6 million | 87.5 million | 27.0 million | 5.9 million |
2023-06-30 | 9.5 million | 86.3 million | - | - |
2023-03-31 | 5.7 million | 82.7 million | 28.1 million | 5.7 million |
2022-12-31 | 3.0 million | 80.6 million | 26.5 million | 5.7 million |
0JDK.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 469000 | 10.2 million |
2023-06-30 | 238000 | 8.0 million |
2023-03-31 | - | 5.7 million |
2022-12-31 | - | 5.7 million |
0JDK.L
Price: $10.30
52 week price:
Earnings Per Share: -2.30 USD
P/E Ratio: -3.97
Exchange: LSE
Sector: Healthcare
Industry: Pharmaceuticals, Biotechnology & Life Sciences
Market Capitalization: 18.7 million